Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD
Mathias Jachs(Medical University of Vienna), Sven Francque(Antwerp University Hospital), Marı́a Isabel Torres(Universidad de Jaén), Shantha Valainathan, Olivier Roux(Inserm), Philip Y. Attalla, José Presa(Unidade Local de Saúde de Trás-os-Montes e Alto Douro), Bogdan Procopeț(Iuliu Hațieganu University of Medicine and Pharmacy), Tomas Guasconi(University of Modena and Reggio Emilia), Vincenza Calvaruso(University of Palermo), Wilhelmus J. Kwanten(Antwerp University Hospital), Ángela Puente(Federico II University Hospital), Paul Thöne(Medical University of Vienna), José Ignacio Fortea(Marqués de Valdecilla University Hospital), Audrey Payancé(Inserm), Monica Lupșor‐Platon(University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca), Carlos A. Pardo(Johns Hopkins University), Marcello Bianchini(University of Modena and Reggio Emilia), Benjamin Maasoumy(Medizinische Hochschule Hannover), Chloé De Broucker(Inserm), Oana Nicoară-Farcău(Iuliu Hațieganu University of Medicine and Pharmacy), José Luís Calleja(Hospital Universitario Puerta de Hierro Majadahonda), Thomas Vanwolleghem(Erasmus MC), Pierre‐Emmanuel Rautou(Inserm), Filippo Schepis(University of Modena and Reggio Emilia), Fanny Turón(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Antonio Colecchia(University of Bologna), Elba Llop(Hospital Universitario Puerta de Hierro Majadahonda), Horia Ştefănescu(Institutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor), Annalisa Berzigotti(University of Bern), Agustı́n Albillos(Universidad de Alcalá), Angelo Armandi(University of Turin), Yuly P. Mendoza(University of Bern), Aitor Odriozola(Marqués de Valdecilla University Hospital), Wim Laleman(University Hospital Münster), Dario Saltini(University of Modena and Reggio Emilia), Lucile Moga(Université Paris Cité), Luís Téllez(Universidad de Alcalá), Virginia Hernández–Gea(Instituto de Salud Carlos III), Thomas Reiberger(ERN GUARD-Heart), Albert Friedrich Stättermayer(Medical University of Vienna), Petra Fischer(Iuliu Hațieganu University of Medicine and Pharmacy), Federico Ravaioli(Azienda USL di Bologna), Michael Trauner(Medical University of Vienna), Andreea Fodor, Jörn M. Schattenberg(Saarland University), Maria Grasso(University of Palermo), Mattias Mandorfer(Medical University of Vienna), T. Issoufaly(Hôpital Louis-Mourier), Juan Carlos García‐Pagán(Instituto de Salud Carlos III)
Cited by 5
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k